Category: Uncategorized
Funding research! A funders or donor’s intent relates to the purposeful state of mind behind the act of giving. The desire and hope that their the gift will contribute to achieve a greater community good is often philanthropist’s underlying intent. The same can be said about the community’s willingness to give or support a cause. […]
VIEW POSTDr Noel Chambers, CEO, The National Foundation for Medical Research and Innovation discusses how funders of research should consider how to influence important activities beyond research that enable translation and impact.
VIEW POSTNFMRI funded 2015 – project updates
Highlighting some of the advances made in NFMRI funded medical research. See more in our annual report. Prof Michael Good AO Institute for Glycomics, Griffith University Field: Rheumatic heart disease (Group A Streptococcus) Innovation: Potential new vaccine Professor Michael Good AO was awarded an NFMRI grant commencing in 2015 to support the production […]
VIEW POSTCould this be a reality? We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]
VIEW POSTIntegrated Technology Research Platforms: Delivering Quality Outcomes for Academic and Industry Researchers
Written by Professor Ian Smith, Monash University Vice-Provost (Research and Research Infrastructure), A number of universities across the globe are recognising the value of Investment in world-class research infrastructure in the form of technology research platforms (TRP’s). These investments are helping to take research and industry collaborations to a new level and also helps create local […]
VIEW POSTSupporting innovations: Prof Michael Good
Professor Michael Good AO talks about NFMRI funding and his research into a new Strep vaccine for rheumatic heart disease and deep tissue infections The ‘Valley of Death’ grant that we recently received from the National Foundation for Medical Research and Innovation (NFMRI) has been a Godsend to our streptococcal vaccine project. Whist there […]
VIEW POSTInteresting analysis of biotechnology venture capital investments
Forbes Magazine has written an interesting article “Where Does All That Biotech Venture Capital Go?” around the Biotechnology Venture Capital industry and an analysis by BIO.
VIEW POSTPhilanthropic giving: Exploring the balance between cause and effect.
Assuming both are important where do you think priority should lie?
VIEW POSTAdvancing biomedical innovations & enabling collaborations: “The long and the short of measuring success”
Measuring success when supporting biomedical research can be difficult. This is particularly relevant if there is no predetermined agreement of what success looks like or no strategy to guide how you contribute to the larger picture. Often governments, researchers and the community use terms such as ‘bench to bedside’ (beginning and end) when considering the […]
VIEW POSTIt’s good to give
Since 2001, wealthy Australian families have been increasingly taking advantage of Private Ancillary Funds (PAFs) as a vehicle to structure their giving. What these funds provide is no surprise; tax deductibility paired with the ability to custom-design your own support to the causes chosen by you and your appointed directors (which are often family members). […]
VIEW POST
